Effect of Atenolol on Hepatic Dysfunction by Evaluating Level of AST

Maria Siddiqui, Mehreen Rasheed, I. Shahid, I. Tanvir, S. Khalid
{"title":"Effect of Atenolol on Hepatic Dysfunction by Evaluating Level of AST","authors":"Maria Siddiqui, Mehreen Rasheed, I. Shahid, I. Tanvir, S. Khalid","doi":"10.54393/pbmj.v6i06.885","DOIUrl":null,"url":null,"abstract":"Hypertension is one of the most important risk factors for morbidity and mortality around the world. Many drugs used to treat hypertension have several side effects. Atenolol used to control hypertension, is an anti-beta-adrenergic agent. It has found to significantly affect the hepatic functions. Objective: To study the effects of atenolol on hepatic dysfunction by measuring AST level in hypertensive patients, taking atenolol alone or in combination with other anti-hypertensive drugs. Methods: The variation in AST level was measured upon use of atenolol alone or in combination with other anti-hypertensive drugs. Out of total 80 patients, 43 were treated with atenolol alone, 37 with atenolol in combination with other anti-hypertensive drugs and 20 were healthy controls. Micro lab tests were used for measurement of AST level. Results: Significant results were found as atenolol cause increase in AST level. Other anti-hypertensive drugs did not affect the AST levels much and the increase in AST level was more significant in patients taking atenolol alone. Conclusions: Atenolol may have efficacy in controlling hypertension, but it causes disturbance in AST levels therefore any other drug in combination with atenolol is recommended to avoid AST variation and eventually hepatic dysfunctions. Further this study may be employed on large scale for strengthening the outcomes of this study","PeriodicalId":19844,"journal":{"name":"Pakistan BioMedical Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan BioMedical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54393/pbmj.v6i06.885","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension is one of the most important risk factors for morbidity and mortality around the world. Many drugs used to treat hypertension have several side effects. Atenolol used to control hypertension, is an anti-beta-adrenergic agent. It has found to significantly affect the hepatic functions. Objective: To study the effects of atenolol on hepatic dysfunction by measuring AST level in hypertensive patients, taking atenolol alone or in combination with other anti-hypertensive drugs. Methods: The variation in AST level was measured upon use of atenolol alone or in combination with other anti-hypertensive drugs. Out of total 80 patients, 43 were treated with atenolol alone, 37 with atenolol in combination with other anti-hypertensive drugs and 20 were healthy controls. Micro lab tests were used for measurement of AST level. Results: Significant results were found as atenolol cause increase in AST level. Other anti-hypertensive drugs did not affect the AST levels much and the increase in AST level was more significant in patients taking atenolol alone. Conclusions: Atenolol may have efficacy in controlling hypertension, but it causes disturbance in AST levels therefore any other drug in combination with atenolol is recommended to avoid AST variation and eventually hepatic dysfunctions. Further this study may be employed on large scale for strengthening the outcomes of this study
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿替洛尔通过评价AST水平对肝功能障碍的影响
高血压是世界范围内发病率和死亡率最重要的危险因素之一。许多治疗高血压的药物都有一些副作用。阿替洛尔用于控制高血压,是一种抗肾上腺素能药物。已发现对肝功能有显著影响。目的:通过测定高血压患者单用阿替洛尔或与其他降压药合用阿替洛尔对肝功能障碍的影响,探讨阿替洛尔对肝功能障碍的影响。方法:测定阿替洛尔单独使用或与其他抗高血压药物合用时AST水平的变化。在80例患者中,43例单独使用阿替洛尔,37例阿替洛尔与其他抗高血压药物联合使用,20例为健康对照。微实验室法测定AST水平。结果:阿替洛尔引起AST水平升高的结果显著。其他降压药对AST水平影响不大,单用阿替洛尔患者AST水平升高更为显著。结论:阿替洛尔可能有控制高血压的作用,但会引起谷丙转氨酶水平的紊乱,因此建议任何其他药物与阿替洛尔联用,以避免谷丙转氨酶变化,最终导致肝功能障碍。本研究可进一步大规模应用,以加强本研究的结果
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical Assessment and Demographic Insights of Lactose Intolerance Among Diarrheal Children at Hyderabad, Pakistan Exploring Genitourinary Syndrome of Menopause: Analysis of Prevalence, Determinants, and Health Impacts in Pakistani Women Patient Satisfaction from Services Provided at Low Vision Clinic in Tertiary Care Hospitals- A Cross-Sectional Study A Comparison of the Protective Effect of Pyridoxine and N-Acetylcysteine in Paracetamol Induced Hepatotoxicity in Rats Quality Assurance in Safe Handling of Hazardous Drugs Among Healthcare Workers in KSA: A Scoping Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1